Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19

• मुख्य लेखकों: Camila Fonseca Amorim da Silva (लेखक), Samanta Omae Camalhonte (लेखक), Michell de Oliveira Almeida (लेखक), Sheila Cruz Araujo (लेखक), Miriam Sannomiya (लेखक), João Henrique Ghilardi Lago (लेखक), Kathia Maria Honorio (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Bioactive compounds against SARS-CoV-2 targets could be potential treatments for COVID-19. Inhibitors of the receptor-binding domain (RBD) on the viral spike protein can block its binding to the human angiotensin-converting enzyme type II (ACE2) receptor. This study presents ligands based on natural...